Literature DB >> 24768741

Genetic variants and animal models in SNCA and Parkinson disease.

Hao Deng1, Lamei Yuan2.   

Abstract

Parkinson disease (PD; MIM 168600) is the second most common progressive neurodegenerative disorder characterized by a variety of motor and non-motor features. To date, at least 20 loci and 15 disease-causing genes for parkinsonism have been identified. Among them, the α-synuclein (SNCA) gene was associated with PARK1/PARK4. Point mutations, duplications and triplications in the SNCA gene cause a rare dominant form of PD in familial and sporadic PD cases. The α-synuclein protein, a member of the synuclein family, is abundantly expressed in the brain. The protein is the major component of Lewy bodies and Lewy neurites in dopaminergic neurons in PD. Further understanding of its role in the pathogenesis of PD through various genetic techniques and animal models will likely provide new insights into our understanding, therapy and prevention of PD.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Genetics; Multiplication; Mutation; Parkinson disease; SNCA gene; Variation

Mesh:

Substances:

Year:  2014        PMID: 24768741     DOI: 10.1016/j.arr.2014.04.002

Source DB:  PubMed          Journal:  Ageing Res Rev        ISSN: 1568-1637            Impact factor:   10.895


  24 in total

1.  Parkin interacting substrate zinc finger protein 746 is a pathological mediator in Parkinson's disease.

Authors:  Saurav Brahmachari; Saebom Lee; Sangjune Kim; Changqing Yuan; Senthilkumar S Karuppagounder; Preston Ge; Rosa Shi; Esther J Kim; Alex Liu; Donghoon Kim; Stephan Quintin; Haisong Jiang; Manoj Kumar; Seung Pil Yun; Tae-In Kam; Xiaobo Mao; Yunjong Lee; Deborah A Swing; Lino Tessarollo; Han Seok Ko; Valina L Dawson; Ted M Dawson
Journal:  Brain       Date:  2019-08-01       Impact factor: 13.501

2.  Complex Effects of the ZSCAN21 Transcription Factor on Transcriptional Regulation of α-Synuclein in Primary Neuronal Cultures and in Vivo.

Authors:  Georgia Dermentzaki; Nikolaos Paschalidis; Panagiotis K Politis; Leonidas Stefanis
Journal:  J Biol Chem       Date:  2016-02-23       Impact factor: 5.157

3.  Structural features of α-synuclein amyloid fibrils revealed by Raman spectroscopy.

Authors:  Jessica D Flynn; Ryan P McGlinchey; Robert L Walker; Jennifer C Lee
Journal:  J Biol Chem       Date:  2017-11-30       Impact factor: 5.157

4.  Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodies.

Authors:  David J Koss; Daniel Erskine; Andrew Porter; Pawel Palmoski; Hariharan Menon; Olivia G J Todd; Marta Leite; Johannes Attems; Tiago F Outeiro
Journal:  Acta Neuropathol Commun       Date:  2022-07-06       Impact factor: 7.578

5.  Activation of tyrosine kinase c-Abl contributes to α-synuclein-induced neurodegeneration.

Authors:  Saurav Brahmachari; Preston Ge; Su Hyun Lee; Donghoon Kim; Senthilkumar S Karuppagounder; Manoj Kumar; Xiaobo Mao; Joo Ho Shin; Yunjong Lee; Olga Pletnikova; Juan C Troncoso; Valina L Dawson; Ted M Dawson; Han Seok Ko
Journal:  J Clin Invest       Date:  2016-06-27       Impact factor: 14.808

6.  The analysis of association between SNCA, HUSEYO and CSMD1 gene variants and Parkinson's disease in Iranian population.

Authors:  Neda Shahmohammadibeni; Simin Rahimi-Aliabadi; Javad Jamshidi; Babak Emamalizadeh; Hossein Ali Shahmohammadibeni; Alireza Zare Bidoki; Haleh Akhavan-Niaki; Hajar Eftekhari; Shokoufeh Abdollahi; Mahmoud Shekari Khaniani; Mahnaz Shahmohammadibeni; Atena Fazeli; Marzieh Motallebi; Shaghayegh Taghavi; Azadeh Ahmadifard; Amir Ehtesham Shafiei Zarneh; Monavvar Andarva; Tahereh Dadkhah; Ehteram Khademi; Elham Alehabib; Mahnoosh Rahimi; Abbas Tafakhori; Minoo Atakhorrami; Hossein Darvish
Journal:  Neurol Sci       Date:  2016-01-05       Impact factor: 3.307

Review 7.  Up-regulation of SNCA gene expression: implications to synucleinopathies.

Authors:  L Tagliafierro; O Chiba-Falek
Journal:  Neurogenetics       Date:  2016-03-07       Impact factor: 2.660

Review 8.  Splicing: is there an alternative contribution to Parkinson's disease?

Authors:  Valentina La Cognata; Velia D'Agata; Francesca Cavalcanti; Sebastiano Cavallaro
Journal:  Neurogenetics       Date:  2015-05-16       Impact factor: 2.660

9.  Generation of SNCA Cell Models Using Zinc Finger Nuclease (ZFN) Technology for Efficient High-Throughput Drug Screening.

Authors:  Warunee Dansithong; Sharan Paul; Daniel R Scoles; Stefan M Pulst; Duong P Huynh
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

10.  Adenovirus-induced Reactive Astrogliosis Exacerbates the Pathology of Parkinson's Disease.

Authors:  Heeyoung An; Hyowon Lee; Seulkee Yang; Woojin Won; C Justin Lee; Min-Ho Nam
Journal:  Exp Neurobiol       Date:  2021-06-30       Impact factor: 3.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.